for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

GlaxoSmithKline Consumer Healthcare Ltd

GLSM.NS

Latest Trade

8,953.65INR

Change

41.60(+0.47%)

Volume

14,643

Today's Range

8,889.00

 - 

8,997.80

52 Week Range

6,801.10

 - 

8,997.80

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
8,912.05
Open
8,910.00
Volume
14,643
3M AVG Volume
0.32
Today's High
8,997.80
Today's Low
8,889.00
52 Week High
8,997.80
52 Week Low
6,801.10
Shares Out (MIL)
42.06
Market Cap (MIL)
376,550.60
Forward P/E
34.79
Dividend (Yield %)
1.17

Latest Developments

More

India's Glaxosmithkline Consumer Healthcare March-Qtr Profit Rises

GlaxosmithKline Consumer Healthcare Says Drugs Inspector Issued Order Of Seizure For Sensodyne Toothpaste

India's Glaxosmithkline Consumer Healthcare Dec Qtr Profit Rises

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About GlaxoSmithKline Consumer Healthcare Ltd

GlaxoSmithKline Consumer Healthcare Limited is a food processing company. The Company offers malt-based food, protein rich food, cereal-based beverage and nutritional food powder. Its products include nutritional products and over the counter (OTC) products. The Company's nutritional products include Horlicks Ninja, Junior Horlicks, Mother's Horlicks, Horlicks Lite, Horlicks Biscuits, Boost, Maltova and Viva. The Company's OTC products include Crocin, a household medicine for relieving pain and body ache; Eno, an antacid for instant relief from acidity, gastric discomfort and heart burn, and Iodex, a pain reliever available under various types, including Iodex Double Power, Iodex Headfast and Iodex Ultra Gel. The Company has manufacturing facilities at Nabha, Punjab; Rajahmundry, Andhra Pradesh, and Sonepat, Haryana. The Company markets its products in India, Sri Lanka, Bangladesh, Nepal, the Middle East, Myanmar, Kenya and Pakistan.

Industry

Food Processing

Contact Info

DLF Plaza Tower, DLF Phase-I

+91.124.4336500

http://www.gsk-ch.in/

Executive Leadership

Patnam Dwarakanath

Non-Executive Chairman of the Board

Vivek Anand

Chief Financial Officer, Director - Finance

Shanu Saksena

Company Secretary & Area Ethics and Compliance Officer

Navneet Saluja

Managing Director, Director

Anup Dhingra

Director – Operations, Wholetime Director

Key Stats

2.27 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

37.7K

2018

43.2K

2019

47.8K

2020(E)

52.4K
EPS (INR)

2017

156.150

2018

166.470

2019

233.690

2020(E)

257.395
Price To Earnings (TTM)
36.54
Price To Sales (TTM)
7.73
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
34.36
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

GSK buys out Novartis in $13 billion consumer healthcare shake-up

GlaxoSmithKline <GSK.L> is buying Novartis <NOVN.S> out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.

BRIEF-India's GlaxoSmithKline Consumer Healthcare Dec Qtr Profit Up 20 Pct

* DEC QUARTER PROFIT 1.64 BILLION RUPEES VERSUS PROFIT OF 1.36 BILLION RUPEES LAST YEAR

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

BRIEF-India's Glaxosmithkline Consumer Healthcare Sept qtr profit up about 4 pct

* Sept quarter net profit 1.92 billion rupees versus profit of 1.84 billion rupees last year

REFILE-Morning News Call - India, November 7

(Corrects to remove item on GlaxoSmithKline Consumer Healthcare post-earnings analyst conference call as the event is slated for Nov 8) To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_11072017.pdf If you...

BRIEF-Glaxosmithkline Consumer's board accepts resignation of formerly executive director

* SAYS BOARD ACCEPTS RESIGNATION OF PUNEET SHARMA FORMERLY EXECUTIVE DIRECTOR, WITH EFFECT FROM JULY 14, 2017

BRIEF-Glaxosmithkline Consumer Nigeria posts HY group pre-tax profit 31.5 mln naira

* HY ENDED JUNE 2017 GROUP PROFIT BEFORE TAX 31.5 MILLION NAIRA VERSUS LOSS OF 1.13 BILLION NAIRA

BRIEF-India's GlaxoSmithKline Consumer Healthcare March-qtr profit up 8.6 pct

* Net profit in March quarter last year was 1.62 billion rupees as per IND-AS; net sales was 11.92 billion rupees

BRIEF-Glaxosmithkline Consumer Healthcare Dec-qtr profit down about 8 pct

* Net profit in dec quarter last year was 1.49 billion rupees as per Ind-AS; net sales was 10.56 billion rupees

BRIEF-GlaxoSmithKline Consumer Healthcare Sept-qtr profit falls about 16 pct

* Net profit in sept quarter last year was 2.20 billion rupees as per Ind-AS; net sales was 11.51 billion rupees Source text: http://bit.ly/2fuCgUy Further company coverage: (Bengaluru newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up